Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Dicerna Pharmaceuticals Inc (NASDAQ:DRNA)

4.33
Delayed Data
As of 12:49pm ET
 +0.18 / +4.34%
Today’s Change
2.42
Today|||52-Week Range
6.10
+50.35%
Year-to-Date
Market Limps Into Weekend
Jul 21 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close4.15
Today’s open4.15
Day’s range4.09 - 4.40
Volume195,812
Average volume (3 months)151,308
Market cap$86.3M
Dividend yield--
Data as of 12:49pm ET, 07/25/2017

Growth & Valuation

Earnings growth (last year)+7.12%
Earnings growth (this year)+21.72%
Earnings growth (next 5 years)--
Revenue growth (last year)+60.33%
P/E ratioNM
Price/Sales202.28
Price/Book2.09

Competitors

 Today’s
change
Today’s
% change
ARQLArQule Inc+0.02+1.63%
LIFEaTyr Pharma Inc-0.10-2.82%
BLRXBioLine RX Ltd+0.01+1.08%
ARLZAralez Pharmaceutica...+0.03+1.81%
Data as of 1:05pm ET, 07/25/2017

Financials

Next reporting dateAugust 10, 2017
EPS forecast (this quarter)-$0.60
Annual revenue (last year)$295.0K
Annual profit (last year)-$59.5M
Net profit margin-20,173.90%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Douglas M. Fambrough
Senior Vice President-
Operations
David W. Miller
Corporate headquarters
Cambridge, Massachusetts

Forecasts